Mathematical Model Shows How SARS-CoV-2 Variants Could Affect Pandemic Trajectory
November 25th 2021The model could help researchers and public health officials interpret the significance of existing variants and design tailored public health responses for various scenarios based on a variant’s characteristic.
Read More
Results From Phase 3 Trials of AZD7442 Show Robust Efficacy of Prevention and Treatment of COVID-19
November 24th 2021The results showed that one 300 mg dose of AZD7442 reduced the risk of developing symptomatic COVID-19 by 83% and one 600 mg dose reduced the risk of developing severe COVID-19 or death (from any cause) by 88% compared to the placebo.
Read More
The FDA has approved maribavir for the treatment of adults and pediatric patients aged 12 years or older and weighing at least 35 kg with post-transplant cytomegalovirus infection/disease that is refractory to treatment with ganciclovir, valganciclovir, cidofovir, or foscarnet.
Read More
Whole-Cell Vaccines Could Fight Urinary Tract Infections, Especially Reoccurring
November 24th 2021Investigators have developed an encapsulated and immobilized individual bacterium cell in crystalline polymeric matric that not only kills the bacterium but preserves and stabilizes the dead cell against high temperature, moisture, and organic solvents. The method utilizes metal-organic frameworks (MOFs).
Read More